Status:
COMPLETED
Hop Compounds and Immune System
Lead Sponsor:
University of Vienna
Conditions:
Inflammatory Response
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The aim of the present study is to determine the effect of Xanthohumol and Iso-alpha-acids from hops on the immune response of healthy participants.
Detailed Description
In this placebo-controlled crossover study a study drink enriched with either a placebo, Xanthohumol, Iso-alpha Acids or a combination of latter is given to the participants. A washout phase before in...
Eligibility Criteria
Inclusion
- healthy, normal weight,
Exclusion
- food intolerances, food allergies, chronic inflammatory diseases, metabolic diseases, viral or bacterial infections within the last 3 weeks of inclusion, intake of immunosupressive medication
Key Trial Info
Start Date :
June 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04847193
Start Date
June 13 2019
End Date
January 27 2021
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vienna
Vienna, Austria, 1090